🔎 Trials Near Me

Hjem › KOL › Texas › Houston

KOL kliniske forsøg i Houston, TX

15 studier for KOL søger deltagere på steder i og omkring Houston (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

RekruttererFase 3
  • Research Site, Houston
  • Research Site, Houston
  • Research Site, Houston
Alder 40 til 80 · Alle køn · Opdateret 2. okt. 2026 · NCT06283966

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

RekruttererFase 3
  • Se Houston- Site Number : 8400120, Houston
  • Aavon Clinical Trials, Llc- Site Number : 8400166, Houston
Alder 40 til 80 · Alle køn · Opdateret 1. okt. 2026 · NCT07190222

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

RekruttererFase 2
  • Baylor College of Medicine Medical Center, Houston
Alder 40 til 75 · Alle køn · Opdateret 25. sep. 2026 · NCT07759245

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

RekruttererFase 3
  • Trio Clinical Trials- Site Number : 8400106, Houston
  • HDH Research- Site Number : 8400104, Houston
  • Baylor College of Medicine- Site Number : 8400076, Houston
  • og 2 flere
Alder 40 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07190209

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

RekruttererFase 2
  • Research Site, Houston
Alder 40 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07082738

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

RekruttererFase 2
  • Baylor College of Medicine, Houston
Alder 40 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

RekruttererFase 3
  • Research Site, Houston
  • Research Site, Houston
  • Research Site, Houston
Alder 40 til 80 · Alle køn · Opdateret 3. sep. 2026 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

RekruttererFase 3
  • Research Site, Houston
  • Research Site, Houston
  • Research Site, Humble · 17 mi væk
Alder 40 til 80 · Alle køn · Opdateret 3. sep. 2026 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

RekruttererFase 2/3
  • Greater Heights & Memorial Pulmonary and Sleep, Houston
  • Houston Pulmonary Sleep and Allergy Associates, Houston
Alder 35 til 80 · Alle køn · Opdateret 31. aug. 2026 · NCT07363694

STRIVE Post-Market Registry Study

RekruttererObservationsstudie
  • University of Texas Health Science Center at Houston, Houston
Alder 18 og opefter · Alle køn · Opdateret 3. aug. 2026 · NCT04302272

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

RekruttererFase 3
  • GSK Investigational Site, Houston
  • GSK Investigational Site, Houston
  • GSK Investigational Site, Houston
Alder 40 til 75 · Alle køn · Opdateret 28. jul. 2026 · NCT07177339

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

Rekrutterer
  • Houston Methodist/Primary Critical Care, Houston
Alder 40 til 84 · Alle køn · Opdateret 24. apr. 2026 · NCT06891755

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

RekruttererFase 3
  • GSK Investigational Site, Houston
Alder 40 til 80 · Alle køn · Opdateret 9. apr. 2026 · NCT06961214

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

RekruttererObservationsstudie
  • Horizon Clinical Research Group, Houston
Alder 50 og opefter · Alle køn · Opdateret 5. aug. 2025 · NCT06122077

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Rekrutterer
  • Respire Research Institute, Houston
Alder 30 og opefter · Alle køn · Opdateret 6. feb. 2025 · NCT05204888

KOL forsøg i andre byer

Andre studier i Houston

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.